Clinical Potential of Targeting Fibroblast Growth Factor‐23 and αKlotho in the Treatment of Uremic Cardiomyopathy
Jonathan P. Law(University Hospitals Birmingham NHS Foundation Trust), Charles J. Ferro(Queen Elizabeth Hospital Birmingham), Chris J. Weston(University of Massachusetts Chan Medical School), John Townend(Queen Elizabeth Hospital Birmingham), Paulus Kirchhof(Universität Hamburg), Ashwin Radhakrishnan(University of Birmingham), Richard P. Steeds(University Hospitals Birmingham NHS Foundation Trust), Larissa Fabritz(University of Birmingham), Luke Pickup(University of Warwick), Anna Price(University Hospitals Birmingham NHS Foundation Trust), Davor Pavlović(University of Birmingham), Helen M. McGettrick(University of Birmingham), Winnie Chua(University of Birmingham), Alan M. Jones(University College Birmingham)
Cited by 32
Related Papers
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
|EP Europace|2016|6.5k
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
|European Heart Journal|2016|6.4k
Guidelines on the management of valvular heart disease (version 2012)
|European Heart Journal|2012|3.6k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012
|European Journal of Heart Failure|2012|2.6k